BPC 157 Injection Dosage and Benefits for Chronic Pain Relief BPC 157 Dosing (Common Protocols), Oral Subcutaneous, 500 mcg daily, Duration: 6 weeks, Intramuscular Peritendinous, 1 mg daily, Duration: 6 weeks, Note:, Not approved by FDA or The Human Lab Rats Injecting Themselves with Peptides Office for Science and Society McGill University BPC 157 Dosing (Common Protocols) Oral Subcutaneous 500 mcg daily Duration: 6 weeks Intramuscular Peritendinous 1 mg daily Duration: 6 weeks Note: Not approved BPC 157 for Foot Pain Houston Podiatrist Explains BPC 157 Benefits, Dosage & Before After Results